Thanks to research, today more people than ever survive cancer and go on to live full and healthy lives. North West Cancer Research want to make this true for everyone
We do this by funding world-class cancer research across the region. We fund research into understanding and stopping the cancers that are most important and significant to the needs of the people of the North West of England and North Wales.
We fund only the highest quality research and are proud to be members of the Association of Medical Research Charities (AMRC). We adhere to their processes and guidance to ensure our funding and the management of our research priorities are transparent and rigorous.
A North West Cancer Research-funded team of researchers, based across the region, have identified a new protein in cancer cells which could lead to improved treatments for head and neck cancer and ovarian cancer patients.
A team of North West Cancer Research-funded researchers is exploring the psychological impact of cancer diagnoses on informal caregivers.
A group of leading researchers are set to investigate why people living in the North West have some of the worst survival rates of Head and Neck cancers, compared with the rest of the country.
PROTACing medulloblastoma: turning existing chemistry upside down to design a new therapeutic approach
Proton beam therapy is one of the most recent significant breakthroughs in cancer treatment.
Dr Gabrielle Grundy, the NWCR Research Fellow at University of Liverpool, is researching the mechanisms of resistance to radiotherapy in head and neck cancers.
A team of cancer researchers, funded by North West Cancer Research, celebrated at Lancaster University the completion of their project and the resulting publication of their book.
Blackpool has recently been selected by NHS England as one of the first sites to develop the new proposed National Screening Programme for Lung Cancer.
Nick Hulbert-Williams spoke about his project exploring the impacts of the Covid-19 pandemic on the psychological wellbeing of cancer patients.
